{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:57:57Z","timestamp":1774933077364,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"capital health research and development"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijcard.2020.06.021","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T13:51:30Z","timestamp":1593179490000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study"],"prefix":"10.1016","volume":"318","author":[{"given":"Dongfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiantao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Paulo Simao","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"D'Ascenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Saucedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Wilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter J.","family":"Kikkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Nu\u00f1ez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Ariza-Sole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Liebetrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuma","family":"Kawaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenon","family":"Huczek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoping","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masa-aki","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Southern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Kalpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijcard.2020.06.021_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCINTERVENTIONS.114.001360","article-title":"Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial","volume":"7","author":"Stone","year":"2014","journal-title":"Circ. Cardiovasc. Interv"},{"issue":"12","key":"10.1016\/j.ijcard.2020.06.021_bb0010","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/clc.20356","article-title":"A prior myocardial infarction: how does it affect management and outcomes in recurrent acute coronary syndromes?","volume":"31","author":"Motivala","year":"2008","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2020.06.021_bb0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/eurjhf\/hfq194","article-title":"Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction","volume":"13","author":"Thune","year":"2011","journal-title":"Eur. J. Heart Fail."},{"issue":"8","key":"10.1016\/j.ijcard.2020.06.021_bb0020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/hrt.2009.188607","article-title":"The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction","volume":"96","author":"Bramlage","year":"2010","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.ijcard.2020.06.021_bb0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2459\/JCM.0000000000000362","article-title":"BleeMACS: rationale and design of the study","volume":"17","author":"D\u2019Ascenzo","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"10065","key":"10.1016\/j.ijcard.2020.06.021_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","article-title":"Acute myocardial infarction","volume":"389","author":"Reed","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ijcard.2020.06.021_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001197","article-title":"National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010","volume":"3","author":"Chaudhry","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"20","key":"10.1016\/j.ijcard.2020.06.021_bb0040","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9665","key":"10.1016\/j.ijcard.2020.06.021_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ijcard.2020.06.021_bb0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcard.2020.06.021_bb0055","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: a platelet inhibition and patient outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2020.06.021_bb0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2017.11.008","article-title":"1-year outcomes of patients undergoing primary angioplasty for myocardial infarction treated with Prasugrel versus Ticagrelor","volume":"71","author":"Motovska","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcard.2020.06.021_bb0065","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.116.024823","article-title":"Prasugrel versus Ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: multicenter randomized PRAGUE-18 study","volume":"134","author":"Motovska","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2020.06.021_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1735-3327.113319","article-title":"The pleotropic role of statins: could it be the imminent host modulation agent in periodontics?","volume":"10","author":"Grover","year":"2013","journal-title":"Dent. Res J. (Isfahan)"},{"issue":"10059","key":"10.1016\/j.ijcard.2020.06.021_bb0075","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.ijcard.2020.06.021_bb0080","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of Evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"Jama"},{"issue":"18","key":"10.1016\/j.ijcard.2020.06.021_bb0085","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ijcard.2020.06.021_bb0090","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2020.06.021_bb0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.ijcard.2020.06.021_bb0100","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.06.021_bb0105","doi-asserted-by":"crossref","unstructured":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation 1998; 97(22):2202\u20132212.","DOI":"10.1161\/01.CIR.97.22.2202"},{"issue":"6","key":"10.1016\/j.ijcard.2020.06.021_bb0110","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9343(03)00435-2","article-title":"Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction","volume":"115","author":"Rodrigues","year":"2003","journal-title":"Am. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2020.06.021_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The survival of myocardial infarction long-term evaluation (SMILE) study investigators","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.ijcard.2020.06.021_bb0120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jacc.2016.01.050","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction","volume":"67","author":"Evans","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2020.06.021_bb0125","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcin.2013.12.206","article-title":"Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"7","author":"Yang","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"issue":"14","key":"10.1016\/j.ijcard.2020.06.021_bb0130","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ijcard.2020.06.021_bb0135","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","article-title":"Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (effect of Metoprolol in Cardioprotection during an acute myocardial infarction)","volume":"63","author":"Pizarro","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"24","key":"10.1016\/j.ijcard.2020.06.021_bb0140","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/eurheartj\/ehm489","article-title":"Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials","volume":"28","author":"Cucherat","year":"2007","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.ijcard.2020.06.021_bb0145","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"Beta-blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2020.06.021_bb0150","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.ijcard.2020.06.021_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2012.07.064","article-title":"Pathogenesis of acute coronary syndromes","volume":"61","author":"Crea","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.06.021_bb0160","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijcard.2017.05.121","article-title":"Recurrent acute coronary syndrome and mechanisms of plaque instability","volume":"243","author":"Di Vito","year":"2017","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320333994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320333994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:47:46Z","timestamp":1759092466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320333994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"alternative-id":["S0167527320333994"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.06.021","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}